Cargando...

Molecular markers and prediction of response to immunotherapy in non-small cell lung cancer, an update

Immunotherapy represents one of the most promising therapeutic approaches in lung cancer, however 50% of lung cancer patients will not respond to this treatment, while others will have transitory or durable responses. Because side effects may be life threatening and treatment costs remain very high,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Thorac Dis
Autores principales: Blons, Hélène, Garinet, Simon, Laurent-Puig, Pierre, Oudart, Jean-Baptiste
Formato: Artigo
Lenguaje:Inglês
Publicado: AME Publishing Company 2019
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6353739/
https://ncbi.nlm.nih.gov/pubmed/30775025
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2018.12.48
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!